iShares Neuroscience and Healthcare ETF
BlackRock, Inc. IBRN ETF
| IBRN Price | $25.1496 |
Market Cap | $3.75M |
| Annual Dividend Yield | 0.40% |
Annual Dividend | $0.10 |
| Yearly Management Fee | 0.47% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Pharma, biotech & life sciences |
Last 24h Volume | $187 |
| Portfolio Management Company | BlackRock, Inc. |
Discount/Premium to NAV | 0.05% |
| Inception Date | Aug 24, 2022 |
Market Cap Rank | 4123 |
| Monthly AUM Growth | 8.79% |
Holdings Region | Global |
| Management Style | Passive |
Leverage | Non-Leveraged |
iShares Neuroscience and Healthcare ETF is an ETF issued by BlackRock, Inc. on Aug 24 2022.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of IBRN ETF according to its net asset value is premiumed at 0.05%.
While the total value of the fund shows $302.51K increase compared to the previous month, its price is traded daily at a increase of 0.09%.
The annual dividend yield of IBRN ETF is 0.40%, whereas its main asset area is Global.
IBRN ETF, whose 24-hour total volume is $187, has experienced a $0 cash outflow in the last month.
In addition, iShares Neuroscience and Healthcare ETF's 3-month net asset value total return is 15.12%.
IBRN ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| 0.09% |
2.82% |
9.20% |
14.47% |
2.35% |
-2.89% |
-1.77% |
IBRN ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| 8.03% |
15.12% |
-1.30% |
-4.11% |
-1.30% |
-1.30% |
IBRN ETF Fund Flows Chart
IBRN ETF Market Cap Chart
IBRN ETF NAV Growth Chart
IBRN ETF Comments
no comments yet